Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$630M |
| 2 |
Nike
NKE
|
+$627M |
| 3 |
XYZ
Block Inc
XYZ
|
+$306M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$295M |
| 5 |
FedEx
FDX
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
Meta Platforms (Facebook)
META
|
+$669M |
| 3 |
AbbVie
ABBV
|
+$567M |
| 4 |
Corning
GLW
|
+$343M |
| 5 |
McDonald's
MCD
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Consumer Discretionary | 16.55% |
| 3 | Financials | 13.82% |
| 4 | Healthcare | 12.55% |
| 5 | Communication Services | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
451
Chimera Investment
CIM
$1.04B
| $10.5M | 0.01% |
201,432
| – | – |
|
452
Box
BOX
$4.37B
| $10.5M | 0.01% |
+509,709
| New | +$11M |
|
|
MRNS
453
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $10.4M | 0.01% |
683,906
+9,768
| +1% | +$233K |
|
454
Wheaton Precious Metals
WPM
$49.5B
| $10.4M | 0.01% |
509,171
-210,760
| -29% | -$4.33M |
|
455
Sunrun
RUN
$2.34B
| $9.98M | 0.01% |
1,118,189
+151,485
| +16% | +$1.02M |
|
|
REVG
456
DELISTED
REV Group
REVG
| $9.97M | 0.01% |
480,416
+406,493
| +550% | +$11M |
|
|
FMI
457
DELISTED
Foundation Medicine, Inc.
FMI
| $9.85M | 0.01% |
+125,096
| New | +$9.23M |
|
458
B&G Foods
BGS
$287M
| $9.85M | 0.01% |
415,540
+2,567
| +0.6% | +$78.5K |
|
|
459
Corning
GLW
$119B
| $9.78M | 0.01% |
350,917
-11,140,517
| -97% | -$343M |
|
460
Cogent Biosciences
COGT
$6.65B
| $9.78M | 0.01% |
+224,189
| New | +$9.96M |
|
|
BPL
461
DELISTED
Buckeye Partners, L.P.
BPL
| $9.6M | 0.01% |
256,626
-14
| -0% | -$680 |
|
|
PSDO
462
DELISTED
Presidio, Inc. Common Stock
PSDO
| $9.51M | 0.01% |
607,975
-503,183
| -45% | -$8.4M |
|
463
WSFS Financial
WSFS
$4.12B
| $9.2M | 0.01% |
192,003
+227
| +0.1% | +$11.2K |
|
464
ProQR Therapeutics
PRQR
$243M
| $9.07M | 0.01% |
2,950,374
+314,822
| +12% | +$1.01M |
|
465
HealthEquity
HQY
$8.41B
| $8.74M | 0.01% |
144,391
+4,119
| +3% | +$223K |
|
|
APLS
466
DELISTED
Apellis Pharmaceuticals
APLS
| $8.38M | 0.01% |
379,151
-227,774
| -38% | -$4.48M |
|
|
CWEN.A
467
DELISTED
Clearway Energy Class A
CWEN.A
| $8.33M | 0.01% |
506,606
| – | – |
|
|
NSU
468
DELISTED
Nevsun Resources Ltd.
NSU
| $7.9M | 0.01% |
3,314,592
-1,000,083
| -23% | -$2.29M |
|
469
Adicet Bio
ACET
$85.2M
| $7.81M | 0.01% |
+7,282
| New | +$13.4M |
|
|
VTLE
470
DELISTED
Vital Energy
VTLE
| $7.65M | 0.01% |
43,927
-57,457
| -57% | -$10.7M |
|
471
NCS Multistage Holdings
NCSM
$123M
| $7.53M | 0.01% |
25,109
-8,032
| -24% | -$2.63M |
|
472
Savara
SVRA
$1.12B
| $7.21M | 0.01% |
783,622
+67,952
| +9% | +$800K |
|
473
Select Water Solutions
WTTR
$2.3B
| $7.11M | 0.01% |
563,376
+136,277
| +32% | +$2.23M |
|
474
iRhythm Holdings
IRTC
$3.85B
| $7.05M | 0.01% |
112,037
+15,621
| +16% | +$967K |
|
475
Atara Biotherapeutics
ATRA
$75.5M
| $7.05M | 0.01% |
+7,228
| New | +$6.59M |
|
Similar funds
Jennison Associates's Q1 2018 Portfolio in Review
As of Q1 2018, Jennison Associates held 730 positions worth $101B, down 0.67% from $101B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jennison Associates withdrew a net $4.02B in Q1 2018, closing 79 positions and reducing 339 holdings. Its most notable exit was Newell Brands, an estimated $95.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in Emerson Electric worth $113M.
- Jennison Associates's largest Q1 2018 buy was Emerson Electric: 1,658,090 shares worth $113M.
- Jennison Associates added most to PNC Financial Services in Q1 2018, an estimated $630M increase.
- Jennison Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $1.2B.
- Jennison Associates fully exited Newell Brands in Q1 2018, selling an estimated $95.7M.
- Jennison Associates's ten largest holdings make up 28% of its $101B portfolio in Q1 2018.
- Jennison Associates opened 81 new positions and closed 79 in Q1 2018.
- Jennison Associates's portfolio value fell 0.67% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q1 2018, filed 20 Apr 2018.